Abstract
The tumor microenvironment is a crucial player in the ability of cancer cells to acquire the ability to survive under the hypoxic environment and promote migration and invasion. Translational regulation is an essential part of cancer development and progression. Protein synthesis consumes considerable cellular metabolic energy and is therefore highly regulated, in turn controlling tumor cell proliferation and survival in extreme tumor-host conditions. Protein synthesis is typically downregulated by hypoxia, impairing cell proliferation and migration. Here, we show that breast cancer cells expressing integrin αvβ3, when engaging the extracellular matrix (ECM) protein vitronectin, strongly upregulate both mTOR activity and cap-dependent mRNA translation, which overrides their inhibition by hypoxia and facilitates tumor cell invasion. Interaction of vitronectin with integrin αvβ3 results in the continued activation of the kinase mTOR despite hypoxia through a mechanism that is dependent on integrin-linked kinase but is independent of focal adhesion kinase. Continuous activation of mTOR despite hypoxia involves release of translation initiation factor eIF4E from its repressor protein 4E-BP1, which is required for vitronectin-mediated tumor cell invasion. As integrin αvβ3 is associated with breast cancer cell invasion and metastasis to bone, we propose that the interaction with specific ECM proteins can influence cancer cell invasion, in part, by hyperactivation of mTOR, thereby promoting and sustaining protein synthesis under hypoxic conditions.
Highlights
Tumor cells and their microenvironment maintain a dynamic interaction, exchanging growth factors and cytokines and transforming a local extracellular matrix (ECM) into an activated stroma [1, 2]
We show that vitronectin engagement of integrin avb3, typically present on breast cancer cells metastatic to bone, hyperactivates mTOR, even during hypoxia, thereby overriding the downregulation of cap-dependent mRNA translation
We show that stimulation of breast cancer cell mTOR by integrin avb3vitronectin interaction is linked to strongly increased tumor cell invasion during hypoxia, through a mechanism that involves integrin-linked kinase (ILK) but not focal adhesion kinase (FAK), and mTOR activation of eIF4E-dependent mRNA translation
Summary
Tumor cells and their microenvironment maintain a dynamic interaction, exchanging growth factors and cytokines and transforming a local extracellular matrix (ECM) into an activated stroma [1, 2]. Hypoxia downregulates mTORC1, activating (dephosphorylating) 4EBP1, in turn sequestering eIF4E and downregulating capdependent mRNA translation [6, 9] Both the noncellular structural components of the ECM [10,11,12] and hypoxia [6] can regulate protein synthesis, but their interaction has never been extensively investigated. We show that vitronectin engagement of integrin avb, typically present on breast cancer cells metastatic to bone, hyperactivates mTOR, even during hypoxia, thereby overriding the downregulation of cap-dependent mRNA translation. We show that stimulation of breast cancer cell mTOR by integrin avb3vitronectin interaction is linked to strongly increased tumor cell invasion during hypoxia, through a mechanism that involves integrin-linked kinase (ILK) but not focal adhesion kinase (FAK), and mTOR activation of eIF4E-dependent mRNA translation. Integrin-mediated stimulation of protein synthesis directed by specific ECM components plays an important role in promoting hypoxia resistance and tumor cell invasion
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.